Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5‐year depression trajectories using latent class growth analysis. Issue 8 (16th May 2017)

• Record Type: Journal Article
• Authors: Whitworth, S. R.; Bruce, D. G.; Starkstein, S. E.; Davis, W. A.; Davis, T. M. E.; Skinner, T. C.; Bucks, R. S.
• Is Part Of: Diabetic medicine. Volume 34:Issue 8(2017)
• Page Start: 1108
• Page End: 1115
• Publication Date: 2017-05-16
• Subjects: Diabetes -- Periodicals; 616.462
• DOI: 10.1111/dme.13372
• Languages: English
• ISSNs: 0742-3071

Abstract

Abstract: Aims: To describe the long‐term trajectories of depression symptom severity in people with Type 2 diabetes, and to identify predictors and associates of these trajectories. Methods: A community‐dwelling cohort of 1201 individuals with Type 2 diabetes from the Fremantle Diabetes Study Phase II was followed for 5 years. The nine‐item version of the Patient Health Questionnaire was administered annually to assess depression symptoms, and biomedical and psychosocial measures were assessed at baseline and biennially. Latent class growth analysis was used to identify classes of depression severity trajectories and associated outcomes, and logistic regression models were used to determine predictors of class membership. Results: Three trajectories of depression symptoms were identified: continuously low depression symptoms (85.2%); gradually worsening symptoms that then began to improve (persistent depression – low‐start; 7.3%); and gradually improving symptoms which later worsened (persistent depression – high‐start; 7.5%). Younger age, being a woman, and a lifetime history of major depressive disorder, were associated with greater risk of persistent depression symptoms. Persistent depression was associated with consistently higher BMI over time, but not with changes in HbA1c or self‐monitoring of blood glucose. Conclusions: A subset of individuals with Type 2 diabetes is at risk of depression symptoms that remain elevated over time. Younger, overweight individuals with a history of depression may benefit from early and intensive depression management and ongoing follow‐up as part of routine Type 2 diabetes care. What's new?: Major depression confers a poor prognosis for individuals with Type 2 diabetes, yet the course of depression symptoms in this population has not been examined Our findings show that a subgroup of this population experience persistent depression symptoms that do not remit over a 5‐year period A lifetime history of major depression and higher BMI are significant risk factors for persistent depression Routine monitoring of depression symptom severity as part of Type 2 diabetes care, particularly for those with a lifetime history of major depression, may enable earlier and more targeted intervention for at‐risk individuals